Stemtech (STEK) Free Cash Flow (2012 - 2025)
Stemtech's (STEK) quarterly Free Cash Flow came in at $127001.0 in Q4 2025, up 146.88% year-on-year from $51442.9 in Q4 2024, and up 408.59% quarter-over-quarter from $24971.0 in Q3 2025.
Stemtech (STEK) Free Cash Flow (2012 - 2025) Analysis & Trends
Stemtech has disclosed Free Cash Flow across 14 years of filings, most recently posting $127001.0 for Q4 2025.
- Free Cash Flow for Q4 2025 came in at $127001.0, up 146.88% year-over-year; the trailing twelve-month figure through Dec 2025 was -$483583.0 (up 19.56% YoY), and the FY2025 annual result was -$483583.0, up 19.56% from the prior year.
- Free Cash Flow came in at $127001.0 for Q4 2025 at Stemtech, up from $24971.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.0 million in Q1 2024 to a low of -$1.5 million in Q4 2021.
- The 5-year median for Free Cash Flow is -$236092.0 (2022), against an average of -$312591.7.
- Peak annual rise in Free Cash Flow reached 277.06% in 2024, while the deepest fall reached 21931.31% in 2024.
- Stemtech's Free Cash Flow stood at -$1.5 million in 2021, then jumped by 84.46% to -$240798.0 in 2022, then plunged by 370.1% to -$1.1 million in 2023, then jumped by 76.07% to -$270920.0 in 2024, then surged by 146.88% to $127001.0 in 2025.
- The last three Free Cash Flow figures came in at $127001.0 (Q4 2025), $24971.0 (Q3 2025), and $74952.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Stemtech | - | - | 354,677.00 | 127,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,001.00 |
| Dec 31, 2025 | 127,001.00 |
| Sep 30, 2025 | 24,971.00 |
| Sep 30, 2025 | 24,971.00 |
| Jun 30, 2025 | 74,952.00 |
| Jun 30, 2025 | 74,952.00 |
| Mar 31, 2025 | -710,507.00 |
| Mar 31, 2025 | -710,507.00 |
| Dec 31, 2024 | -270,920.00 |
| Dec 31, 2024 | -270,920.00 |
| Sep 30, 2024 | -1.17 Mn |
| Sep 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -176,358.00 |
| Jun 30, 2024 | -176,358.00 |
| Mar 31, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | -1.13 Mn |
| Dec 31, 2023 | -1.13 Mn |
| Sep 30, 2023 | -5,317.00 |
| Sep 30, 2023 | -5,317.00 |